Hudson Executive Capital is a fund manager in New York with $1.45 bn assets under management.
Company profile
Website
Employees
Incorporated
Location
Fiscal year end
Industry
SEC CIK
Corporate docs
IRS number
472878186
SEC advisor number
801-96334
FINRA CRD number
175032
AUM ?
$1.22 bn
(as of 31 Mar 23)
Accounts
9
(as of 31 Mar 23)
Employees
10
(8 investment advisory or research)
Address
Hudson Executive Capital
570 LEXINGTON AVENUE, 35TH FLOOR
NEW YORK
NY 10022
570 LEXINGTON AVENUE, 35TH FLOOR
NEW YORK
NY 10022
Phone
(212) 521-8495
Ownership
Fund structure | AUM | Fund type |
---|---|---|
Hudson Executive Capital LP | $1.45 bn | |
Hec Investment Fund Cayman Master LTD | $797.36 mm | Hedge Fund |
Hec SPV II Cayman LP | ||
Hec SPV II Master Fund LP | ||
Hec SPV II USA LP | ||
Hec Master Fund LP | $622.33 mm | Hedge Fund |
Hec Intermediate Fund LP | ||
Hec Offshore Fund LTD | ||
Hec Onshore Fund LP | ||
Hec SPV IV LP | $26.51 mm | Hedge Fund |
Hec SPV V LP | Hedge Fund |
Latest filings (excl ownership)
DFAN14A
Additional proxy materials by non-management
20 Apr 20
DFAN14A
Additional proxy materials by non-management
9 Apr 20
DFAN14A
Additional proxy materials by non-management
9 Apr 20
DFRN14A
Revised proxy by non-management
9 Apr 20
DFAN14A
Additional proxy materials by non-management
6 Apr 20
DFAN14A
Additional proxy materials by non-management
6 Apr 20
DFAN14A
Additional proxy materials by non-management
6 Apr 20
DFRN14A
Revised proxy by non-management
31 Mar 20
DFAN14A
Additional proxy materials by non-management
30 Mar 20
DFAN14A
Additional proxy materials by non-management
24 Mar 20
Latest ownership filings
4
Douglas L Braunstein
21 Feb 24
SC 13D/A
CANTALOUPE, INC.
21 Feb 24
144
CANTALOUPE, INC.
21 Feb 24
13F-HR
Quarterly holdings report by institutional manager
14 Feb 24
13F-HR
Quarterly holdings report by institutional manager
14 Nov 23
13F-HR
Quarterly holdings report by institutional manager
14 Aug 23
SC 13D/A
ViewRay, Inc.
21 Jul 23
13F-HR
Quarterly holdings report by institutional manager
15 May 23
13F-HR
Quarterly holdings report by institutional manager
14 Feb 23
SC 13D/A
Akoya Biosciences, Inc.
7 Feb 23